NO172389C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler

Info

Publication number
NO172389C
NO172389C NO892059A NO892059A NO172389C NO 172389 C NO172389 C NO 172389C NO 892059 A NO892059 A NO 892059A NO 892059 A NO892059 A NO 892059A NO 172389 C NO172389 C NO 172389C
Authority
NO
Norway
Prior art keywords
benzotiazoles
preparation
therapeutic active
analogue procedure
analogue
Prior art date
Application number
NO892059A
Other languages
English (en)
Norwegian (no)
Other versions
NO892059L (no
NO172389B (no
NO892059D0 (no
Inventor
Anton Franz Josef Fliri
Rodney Caughren Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO892059D0 publication Critical patent/NO892059D0/no
Publication of NO892059L publication Critical patent/NO892059L/no
Publication of NO172389B publication Critical patent/NO172389B/no
Publication of NO172389C publication Critical patent/NO172389C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Graft Or Block Polymers (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO892059A 1988-05-24 1989-05-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler NO172389C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19803488A 1988-05-24 1988-05-24

Publications (4)

Publication Number Publication Date
NO892059D0 NO892059D0 (no) 1989-05-23
NO892059L NO892059L (no) 1989-11-27
NO172389B NO172389B (no) 1993-04-05
NO172389C true NO172389C (no) 1993-07-14

Family

ID=22731735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892059A NO172389C (no) 1988-05-24 1989-05-23 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler

Country Status (25)

Country Link
EP (1) EP0343893B1 (de)
JP (1) JPH0678331B2 (de)
KR (1) KR910006864B1 (de)
CN (1) CN1023700C (de)
AT (1) ATE79114T1 (de)
AU (1) AU601905B2 (de)
CA (1) CA1328871C (de)
DD (1) DD283815A5 (de)
DE (1) DE68902358T2 (de)
DK (1) DK249389A (de)
ES (1) ES2043012T3 (de)
FI (1) FI892498A (de)
GR (1) GR3005844T3 (de)
HU (1) HU202507B (de)
IE (1) IE891667L (de)
IL (1) IL90337A0 (de)
MX (1) MX173140B (de)
MY (1) MY106035A (de)
NO (1) NO172389C (de)
NZ (1) NZ229234A (de)
PL (1) PL154875B1 (de)
PT (1) PT90622B (de)
SU (1) SU1681728A3 (de)
YU (1) YU47019B (de)
ZA (1) ZA893862B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2790299B2 (ja) * 1989-02-01 1998-08-27 保土谷化学工業株式会社 ペンゾチアゾール誘導体
US5262400A (en) * 1991-06-20 1993-11-16 Merck & Co., Inc. 4α-substituted avermectin derivatives
US6100423A (en) * 1995-08-30 2000-08-08 G. D. Searle & Co. Amino benzenepropanoic acid compounds and derivatives thereof
ES2161373T3 (es) * 1995-08-30 2001-12-01 Searle & Co Derivados de meta-guanidina, urea, tiourea o acido azaciclico-aminobenzoico como antagonistas de integrinas.
US5716281A (en) * 1995-11-27 1998-02-10 Sega Enterprises, Ltd. Game apparatus using a vehicle with an optical image synthesizing system
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
IL135176A0 (en) 1997-11-10 2001-05-20 Bristol Myers Squibb Co Benzothiazole derivatives and pharmaceutical compositions containing the same
EP0928793B1 (de) * 1998-01-02 2002-05-15 F. Hoffmann-La Roche Ag Thiazol-Derivate
WO1999052861A1 (de) * 1998-04-09 1999-10-21 Institut für Diagnostikforschung GmbH an der Freien Universität Berlin Neue benzylguanidinderivate für die therapie, in-vivo- und in-vitro-diagnostik
ATE385794T1 (de) 2000-06-21 2008-03-15 Hoffmann La Roche Benzothiazolderivate zur behandlung von alzheimer und parkinson
US6624163B2 (en) * 2001-11-29 2003-09-23 Hoffman-La Roche Inc. Benzothiazole derivatives
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
CN100357283C (zh) * 2002-04-02 2007-12-26 中国科学院上海药物研究所 一类甲硫氨酰氨肽酶抑制剂
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
CA2567703C (en) 2004-05-24 2013-03-05 F. Hoffmann-La Roche Ag 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
ES2309814T3 (es) 2004-11-05 2008-12-16 F. Hoffmann-La Roche Ag Proceso para la obtencion de derivados del acido isonicotinico.
SI1863818T1 (sl) 2005-03-23 2010-05-31 Hoffmann La Roche Derivati acetilenil pirazolo pirimidina kot antagonisti mglur
BRPI0616571A2 (pt) 2005-09-27 2011-06-21 Hoffmann La Roche oxadiazolil pirazol-piridiminas como antagonistas de mglur2, processo para sua preparação, composição farmacêutica que os contém e uso dos mesmo
EP1994017A2 (de) * 2006-03-15 2008-11-26 4Sc Ag Neue heterocyclische nf-kb-inhibitoren
GB0619325D0 (en) 2006-09-30 2006-11-08 Univ Strathclyde New compounds
EP2311842A3 (de) * 2008-06-24 2011-07-13 Takeda Pharmaceutical Company Limited PI3K/M TOR Inhibitoren
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
AU2012315953A1 (en) * 2011-09-30 2014-04-03 Kineta, Inc. Anti-viral compounds
WO2013111875A1 (ja) 2012-01-27 2013-08-01 国立大学法人京都大学 多能性幹細胞の心筋分化誘導法
US10196609B2 (en) 2013-03-08 2019-02-05 Kyoto University Composition for promoting cardiac differentiation of pluripotent stem cell comprising EGFR inhibitor
WO2015037706A1 (ja) * 2013-09-13 2015-03-19 国立大学法人京都大学 多能性幹細胞の心筋分化を促進する化合物
EP3150705B1 (de) 2014-05-30 2019-05-15 Kyoto University Verfahren zur induktion von myokardialer differenzierung von pluripotenten stammzellen mithilfe einer verbindung mit niedrigem molekulargewicht
CN109776486A (zh) * 2019-02-26 2019-05-21 武汉松石科技股份有限公司 一种硫酸亚丙酯的制备方法
CN110590735B (zh) * 2019-09-30 2021-07-23 江苏国泰超威新材料有限公司 一种环状硫酸酯的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61225168A (ja) * 1985-03-30 1986-10-06 Nippon Tokushu Noyaku Seizo Kk 新規ベンズアミド、その製法及び殺虫剤
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
GB8611606D0 (en) * 1986-05-13 1986-06-18 Fbc Ltd Fungicides

Also Published As

Publication number Publication date
PT90622A (pt) 1989-11-30
NZ229234A (en) 1990-09-26
IL90337A0 (en) 1989-12-15
KR890017248A (ko) 1989-12-15
MY106035A (en) 1995-03-31
CN1023700C (zh) 1994-02-09
NO892059L (no) 1989-11-27
CA1328871C (en) 1994-04-26
GR3005844T3 (de) 1993-06-07
DK249389D0 (da) 1989-05-23
FI892498A0 (fi) 1989-05-23
DK249389A (da) 1989-11-27
HU202507B (en) 1991-03-28
ES2043012T3 (es) 1993-12-16
ZA893862B (en) 1991-01-30
YU47019B (sh) 1994-11-15
MX16158A (es) 1993-06-01
IE891667L (en) 1989-11-24
NO172389B (no) 1993-04-05
DE68902358T2 (de) 1992-12-10
PL154875B1 (en) 1991-09-30
JPH0217181A (ja) 1990-01-22
DD283815A5 (de) 1990-10-24
AU3509889A (en) 1989-11-30
SU1681728A3 (ru) 1991-09-30
CN1037898A (zh) 1989-12-13
EP0343893B1 (de) 1992-08-05
JPH0678331B2 (ja) 1994-10-05
AU601905B2 (en) 1990-09-20
KR910006864B1 (ko) 1991-09-09
NO892059D0 (no) 1989-05-23
MX173140B (es) 1994-02-02
PL279613A1 (en) 1989-11-27
DE68902358D1 (de) 1992-09-10
ATE79114T1 (de) 1992-08-15
PT90622B (pt) 1994-10-31
FI892498A (fi) 1989-11-25
EP0343893A1 (de) 1989-11-29
HUT51606A (en) 1990-05-28
YU105989A (en) 1990-08-31

Similar Documents

Publication Publication Date Title
NO172389C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler
NO169493C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive peptid-derivater
NO172801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO170727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyran-derivater
NO169900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (ih-azol-1-ylmetyl)substituerte benzotriazolderivater
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO172575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzocykloalkanderivater
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO171856C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
NO158876C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater.
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO171857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO171847C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzenderivater
NO168103C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aralkylimidazolderivater
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO168357C (no) Analogifremgangsmaate for fremstilling av terapeutiske aktive disulfider
NO169171C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glycero-3(2)-fosfo-l-serinderivater
NO169589C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater